Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021

October 22, 2021 updated by: Hendrik Jan Ankersmit, Medical University of Vienna
The overall project aim is to study outcomes after COVID-19 and influenza hospitalisation from 2016 - 2021 by retrieving data from the main social security carriers in Austria for the years 2010-2018

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

440000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients with or after Covid-19 or influenza between 2016-2021 in Austria will be included in this study

Description

Inclusion Criteria:

  • Patients with SARS
  • Patients with Covid-19
  • Patients after Covid-19
  • Patients with influenza

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Influenza
Diagnostic test: PCR or antigen test for Covid 19 or Inluenza
PCR or antigen test for Covid 19 or Inluenza
Covid 19
Diagnostic test: PCR or antigen test for Covid 19 or Inluenza
PCR or antigen test for Covid 19 or Inluenza
Control group
hospitalisation due to other disease (not influenza or Covid 19)
Diagnostic test: PCR or antigen test for Covid 19 or Inluenza
PCR or antigen test for Covid 19 or Inluenza

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Mortality
Time Frame: 5 years
Overall mortality after influenza or covid-19
5 years
age distribution
Time Frame: 5 years
age distribution in patients with influenza or covid-19
5 years
risk profile
Time Frame: 5 years
risk profile (e.g. prior diseases, medication) in patients who died due to influenza or covid-19
5 years
newly diagnosed diseases
Time Frame: 5 years
newly diagnosed diseases after influenza or covid-19
5 years
newly prescribed medication
Time Frame: 5 years
newly prescribed medication after influenza or covid-19
5 years
duration of hospitalisation or unemployability
Time Frame: 5 years
duration of hospitalisation or unemployability after influenza or covid-19
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medical University of Vienna

Collaborators

Landesklinikum Sankt Polten
Sicknessfund Burgenland (BGKK)
A.ö. Krankenhaus St. Josef Braunau GmbH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2016

Primary Completion (ACTUAL)

August 31, 2021

Study Completion (ACTUAL)

August 31, 2021

Study Registration Dates

First Submitted

October 19, 2021

First Submitted That Met QC Criteria

October 19, 2021

First Posted (ACTUAL)

October 21, 2021

Study Record Updates

Last Update Posted (ACTUAL)

October 29, 2021

Last Update Submitted That Met QC Criteria

October 22, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AUTCOV-INFLU-STUDY

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Influenza

Clinical Trials on PCR or antigen test for Covid 19 or Inluenza

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe